Related by context. All words. (Click for frequent words.) 70 DCVax 69 DCVax ® Brain 68 Removab 68 DCVax R Brain 68 SIR Spheres 68 OncoVEX 67 YONDELIS 67 Bendamustine 67 ZACTIMA 67 DCVax ® 66 Temsirolimus 66 nonsmall cell lung cancer 66 rituximab Rituxan 66 Vivaglobin 66 PROSTVAC TM 66 IMA# 66 Certolizumab pegol 65 Velcade bortezomib 65 GRNVAC1 65 Aplidin 65 PSMA ADC 65 Quinamed 65 Alocrest 65 Taxotere docetaxel 65 Gleevec resistant 65 trastuzumab Herceptin 65 Gliadel Wafer 65 mertansine 65 Xcellerated T Cells 65 CVac 64 liposomal formulation 64 Hepatocellular Carcinoma HCC 64 Arranon 64 DCVax R 64 bevacizumab Avastin 64 MAGE A3 ASCI 64 Lilly Gemzar 64 trastuzumab DM1 T DM1 64 Xelox 64 Proxinium TM 64 elacytarabine 64 BrachySil TM 64 Gleevec imatinib mesylate 64 Gleevec imatinib 64 Phase Ib II 64 malignant ascites 64 Allovectin 7 64 Degarelix 63 TEMODAL 63 indibulin 63 HuMax CD4 63 HuMax EGFr 63 Teysuno 63 EndoTAG 63 inhaled AAT 63 Allovectin 7 ® 63 cellular immunotherapy 63 PrevOnco 63 SCIg 63 G#DT 63 ToGA 63 Privigen 63 Urocidin 63 tolevamer 63 TransMID 63 anti idiotype 63 OHR/AVR# 63 Ceflatonin 63 vinorelbine tartrate 63 recurrent metastatic 63 BiovaxID 63 OvaRex ® MAb 63 Amrubicin 63 SNT MC# 63 RhuDex ® 63 Oxaliplatin 63 OncoVEX GM CSF 63 HepaGam B 63 efalizumab 63 relapsing remitting MS RRMS 63 Avastin bevacizumab 63 APTIVUS R 63 biliary tract cancer 63 Pertuzumab 63 teriflunomide 63 thalidomide Thalomid 63 ClearPath HDR 63 Rituxan rituximab 62 ImmuKnow R 62 chemotherapeutic regimen 62 acyclovir Lauriad R 62 Dacogen decitabine 62 PEGylated interferon 62 Nexavar sorafenib 62 nucleotide analogue 62 Phase IIb clinical trials 62 chemotherapy cisplatin 62 DEB# 62 intradermal injection 62 PI3K/Akt pathway inhibitor 62 PROCHYMAL 62 Novartis Afinitor 62 Faslodex 62 HuMax HepC 62 bortezomib Velcade 62 OncoGel 62 TheraSphere 62 vaccine Oncophage 62 Twinrix 62 Campath alemtuzumab 62 doxorubicin Transdrug ® 62 CHAMPION PCI 62 Alferon N 62 dose escalation clinical 62 ACZ# 62 Onconase 62 Bevacizumab Avastin 62 Ozurdex 62 ISF# 62 targeted antifolate 62 relapsed MM 62 Telatinib 62 hepatitis B vaccine Heplisav 62 Rilutek 62 trabectedin 62 Kepivance 62 Hycamtin 62 Certican 62 VNP#M 62 Pemetrexed 62 Evoltra 62 Cloretazine 62 MabThera rituximab 62 Advexin 62 eribulin mesylate 62 BRAF inhibitor 62 ChronVac C R 62 Interferon alfa 62 OvaRex MAb 62 Diamyd ® 62 Neupogen ® 62 ixabepilone 62 virotherapy 62 Xanafide 62 Trastuzumab 62 GRN# 62 Hexvix ® 62 palliative radiotherapy 61 Vectibix panitumumab 61 REMINYL ® 61 ReN# 61 AAV vector 61 Kahalalide F 61 Litx 61 Fludara ® 61 Neuvenge 61 CYT# QbG# 61 CRLX# 61 Tarceva erlotinib 61 alfa interferon 61 recurrent glioblastoma multiforme 61 Sutent sunitinib 61 Xeloda capecitabine 61 Proleukin 61 trastuzumab DM1 61 BEXXAR 61 oseltamivir Tamiflu ® 61 Natalizumab 61 StemEx R 61 Votrient 61 Dacogen injection 61 paclitaxel Taxol ® 61 miglustat 61 PREFLUCEL 61 LEAPS TM 61 eflornithine 61 Bayer HealthCare Onyx Pharmaceuticals 61 VitiGam 61 Imvamune 61 somatostatin analogues 61 BRIM2 61 PrevOnco ™ 61 paclitaxel poliglumex 61 OncoVex 61 NP2 61 Bezielle 61 gastrointestinal stromal tumors GIST 61 radiotherapeutic 61 VIR# 61 Bonefos 61 biotherapies 61 Cellcept 61 microtubule inhibitor 61 lapatinib Tykerb 61 Ontak 61 intravenous immunoglobulin 61 Virulizin ® 61 Neo Bladder Augment 61 Specifid 61 Sym# 61 samalizumab 61 malignant pleural mesothelioma 61 Erbitux cetuximab 61 Paromomycin 61 Pazopanib 61 Rilonacept 61 Azedra 61 NovoTTF 61 corticosteroid dexamethasone 61 neratinib 61 Alemtuzumab 61 ATL# [001] 61 farletuzumab 61 Arimidex anastrozole 61 vismodegib 61 gastrointestinal stromal tumors GISTs 61 Phase III randomized controlled 61 immatics 61 Onrigin 61 IRX 2 61 angiogenesis inhibitor 61 anti CD3 antibody 61 Centralized Procedure 61 metastatic gastric 61 Sorafenib 61 Genasense ® 61 biodegradable implant 61 Gleevec Glivec 61 GAMMAGARD 61 MGd 61 BLP# 61 Temodar ® 61 relapsed ovarian cancer 61 LEUKINE 61 protease inhibitor PI 61 metastatic bladder 60 docetaxel Taxotere ® 60 Taxotere chemotherapy 60 receptor tyrosine kinase inhibitor 60 cediranib 60 Surgical resection 60 Alkeran 60 Crizotinib 60 Dasatinib 60 Apatone 60 Zolinza 60 Roche Xeloda 60 UroVysion 60 Arzerra ofatumumab 60 galiximab 60 Tykerb lapatinib 60 allogeneic cell 60 trastuzumab Herceptin ® 60 Raptiva ® 60 amrubicin 60 icatibant 60 personalized immunotherapy 60 fluoropyrimidine 60 GVAX 60 Revimmune 60 HQK 60 multicenter Phase II 60 Reolysin 60 IRESSA 60 MabCampath 60 QuadraSphere 60 humanized monoclonal antibodies 60 oral ridaforolimus 60 colorectal cancer liver metastases 60 Aptivus ® 60 easypod 60 MyVax 60 biotherapy 60 EFAPROXYN 60 Tarvacin 60 EndoTAG TM -1 60 vemurafenib 60 CELVAPAN H#N# 60 Zemplar 60 docetaxel Taxotere 60 recurrent NSCLC 60 HuMax TAC 60 adefovir dipivoxil 60 SANVAR 60 paclitaxel Taxol 60 GW# [003] 60 Arikace 60 aleglitazar 60 microdose 60 Gefitinib 60 intranasal delivery 60 BAY #-# 60 virosome 60 DermaVir Patch 60 Fodosine 60 Retacrit 60 pediatric acute lymphoblastic 60 daptomycin 60 axitinib 60 intratumoral injection 60 MVA MUC1 IL2 60 Japanese Encephalitis vaccine 60 ChronVac C ® 60 gemcitabine cisplatin 60 Amplimexon 60 Toctino ® alitretinoin 60 Platinol ® cisplatin 60 exemestane Aromasin 60 AFRS TM 60 Torisel 60 Erlotinib 60 ImmuKnow 60 Azacitidine 60 busulfan 60 BRAF inhibitors 60 mismatched bone marrow 60 Solorel 60 Gattex 60 relapsing multiple sclerosis 60 Loramyc R 60 Etravirine 60 INTERCEPT platelets 60 Topotecan 60 etanercept Enbrel 60 Egrifta 60 efaproxiral 60 PROLARIS 60 Zevalin consolidation 60 platelet gel 60 CHOP chemotherapy 60 liposomal doxorubicin 60 Oncotype DX colon cancer 60 immunotherapeutic agent 60 Chronic lymphocytic leukemia 60 cidofovir 60 humanised monoclonal antibody 60 oral antiviral 60 novel immunotherapeutic 60 lumiliximab 60 standard chemotherapy regimen 60 MVA BN 60 midstage trials 60 Olaparib 60 rituximab Rituxan ® 60 riluzole 60 Modified Vaccinia Ankara MVA 60 Gammagard Liquid 60 depsipeptide 60 Cefepime 60 Plenaxis 60 Cerashield 60 antibody MAb 60 Gammagard 60 Vimpat ® lacosamide 60 pretargeting 60 Fingolimod 60 intraoperative radiotherapy 60 histone deacetylase HDAC inhibitor 60 Intercell vaccine 60 autologous transplant 60 concurrent chemoradiation 60 Cytolin R 60 radiolabeled TM# 60 Phase IIIb clinical 60 nucleoside analog 60 Celtura 60 trivalent influenza vaccine 60 VersaFilm 60 erlotinib Tarceva ® 60 Zilver PTX stent 60 NSABP B 60 oxaliplatin Eloxatin 60 anti EGFR antibody 60 Oncophage 60 Ellex 2RT 59 TRIST study 59 CANCIDAS 59 FVIIa 59 Voraxaze 59 BEXXAR Therapeutic Regimen 59 Tesmilifene 59 autologous cellular immunotherapy 59 Ganciclovir 59 ATIR 59 gemcitabine carboplatin 59 Nivestim 59 Gemcitabine 59 vinca alkaloid 59 recombinant adeno associated 59 ONCASPAR 59 Multiferon 59 ZOLINZA 59 assessing T DM1 59 HDR brachytherapy 59 allogeneic HSCT 59 Lung Flute ® 59 Neulasta ® 59 sunitinib malate 59 sorafenib Nexavar 59 monovalent vaccine 59 Ixiaro 59 Omapro 59 TroVax ® 59 Cetuximab 59 GeneICE 59 PEP# [003] 59 cinacalcet 59 subcutaneous formulation 59 pemetrexed Alimta 59 hPAM4 59 GVAX Pancreas Vaccine 59 canakinumab 59 Procoralan 59 chimeric monoclonal antibody 59 UPLYSO 59 EOquin TM 59 Mycograb 59 LungSign TM 59 Herceptin trastuzumab 59 humanised antibody 59 Genentech Herceptin 59 SEPET TM 59 reslizumab 59 Mylotarg 59 ImmunoGen TAP technology 59 mda 7 59 eprotirome 59 Dabigatran etexilate 59 Altastaph 59 Adjuvant chemotherapy 59 Tarceva TM 59 SinuNase TM 59 anti angiogenic agents 59 Remune 59 MammaPrint R 59 Zarnestra 59 Canvaxin 59 BiTE 59 rilonacept 59 HepaSphere Microspheres 59 chemoradiotherapy 59 IIa trials 59 Lodotra 59 immunosuppressive regimens 59 erlotinib Tarceva 59 denileukin diftitox 59 Phase Ib study 59 adeno associated viruses 59 TransMID TM 59 EndoTAGTM 1 59 abiraterone 59 Provenge prostate cancer 59 Alvesco R 59 proteasome inhibitor 59 multidose 59 MYDICAR ® 59 relapsed leukemia 59 Enzastaurin 59 lorvotuzumab mertansine 59 intra arterial chemotherapy 59 Interferon alpha 59 ancrod 59 Zavesca R 59 Liprotamase 59 Intravenous immunoglobulin 59 tyrosine kinase inhibitor 59 pegylated interferon alfa 59 metastatic malignant melanoma 59 Cimzia TM 59 BCR ABL inhibitor 59 paclitaxel Taxol R 59 antifungal therapy 59 Aviptadil 59 idraparinux 59 Syncria 59 Hycamtin ® 59 enzastaurin 59 rhMBL 59 gastrointestinal stromal tumors 59 alvespimycin 59 Fortovase 59 CYT# potent vascular disrupting 59 Catena ® 59 Moxifloxacin 59 calcineurin inhibitor 59 demonstrated antitumor activity 59 Eli Lilly Gemzar 59 pitavastatin 59 anti angiogenic therapy 59 phase IIa clinical 59 investigational therapies 59 Anthim 59 interferon beta 1b 59 AVONEX PEN 59 Shark cartilage 59 Cabazitaxel 59 ganciclovir 59 lyophilized formulation 59 Hexvix 59 Decitabine 59 pharmacokinetic PK study 59 VFEND 59 iniparib 59 metastatic kidney 59 Sebivo 59 Civacir 59 Neuradiab 59 CAELYX 59 abacavir Ziagen 59 topical formulations 59 EVICEL 59 phosphatidylserine PS targeting 59 hormone agonist 59 microwave hyperthermia 59 ximelagatran 59 SCCHN 59 subcutaneous immunotherapy 59 refractory prostate cancer 59 Aplidin R 59 FinESS 59 Clevudine 59 vorinostat 59 docetaxel chemotherapy 59 Scancell 59 Glivec imatinib 59 adipose derived stem cell 59 Panzem NCD 59 Alitretinoin 59 rindopepimut 59 Cancidas 59 albumin bound paclitaxel 59 MVA BN R 59 recombinant antibodies 59 pertuzumab 59 Vidaza azacitidine 59 Angiolix 59 taxane chemotherapy 59 goserelin 59 adult chronic ITP 59 mAbs 59 OrCel 59 plasmid DNA vaccine 59 VitroGro 59 Lucanix 59 Phase #b/#a clinical 59 Vitaxin 59 Irinotecan 59 temozolomide TMZ 59 Targretin capsules 59 Onco TCS 59 Factor Xa inhibitor 59 orally dosed 59 Renal Cell Carcinoma RCC 59 IMC #B 59 p# biomarker 59 photosensitizing agent 59 Phase IIIb study 59 TORISEL 59 Vicinium TM 59 topotecan 59 SCENESSE ® 58 Lovaxin C 58 DermaVir 58 Proellex TM 58 immunotherapeutic vaccine 58 pegfilgrastim 58 radiofrequency ablation RFA 58 CCR5 receptor antagonist 58 peptide antigens 58 radiation chemoradiation 58 HyperAcute 58 Trovax 58 pegylated liposomal doxorubicin 58 Alimta pemetrexed 58 verteporfin 58 BR.# 58 drug Treanda 58 docetaxel Taxotere R 58 Arsenic trioxide 58 zidovudine AZT 58 humanized antibody 58 CardioFit 58 dose escalation phase 58 oral talactoferrin 58 tumor specific antigen 58 Folotyn 58 refractory metastatic colorectal cancer 58 moderately emetogenic 58 Talabostat 58 NeuroVax 58 fosbretabulin 58 Intravenous CP 58 Dendreon Provenge 58 methylnaltrexone 58 EGS# 58 gefitinib Iressa 58 radiation sensitizer 58 ESBA# 58 rALLy trial 58 letrozole Femara 58 Gendicine 58 buccal spray 58 selective orally bioavailable 58 recurrent glioma 58 drug conjugate 58 Hodgkin lymphoma HL 58 recurrent GBM 58 candidate TNFerade biologic 58 phase IIb clinical 58 TheraCIM 58 sipuleucel T 58 novel oral anticoagulant 58 Iressa gefitinib 58 Prolastin R 58 Abiraterone 58 superficial bladder cancer 58 ChemoFx 58 ganetespib 58 MyVax R 58 AERAS-#/Crucell Ad# 58 Noxafil 58 intravenous immunoglobulin IVIg 58 TG# [001] 58 phase IIa 58 Pfizer Sutent 58 Revlimid lenalidomide 58 paromomycin 58 bioartificial liver 58 Taxol ® 58 HuMax Inflam 58 neoadjuvant treatment 58 investigational immunotherapy 58 Combidex 58 ProSavin 58 myelofibrosis polycythemia vera 58 IMP# 58 dalbavancin 58 Bone marrow transplantation 58 TriRima 58 ritonavir boosted 58 kidney urologic 58 ThermoDox R 58 Afatinib 58 NanoStat 58 lenalidomide Revlimid R 58 Maraviroc 58 radioimmunotherapy RIT 58 doxorubicin Transdrug R 58 boosted protease inhibitor 58 Zavesca 58 T#I [002] 58 midstage clinical 58 Imiquimod 58 Instanyl 58 temozolomide Temodar 58 ano genital warts 58 triphendiol 58 CEQ# 58 imexon 58 AAV vectors 58 Lapatinib 58 NeuVax 58 Sorafenib Nexavar 58 generation purine nucleoside 58 valganciclovir 58 Ixempra 58 recombinant interferon 58 tacrolimus ointment 58 injectable formulations 58 immuno therapeutic 58 preoperative chemotherapy 58 mRCC 58 Dabigatran 58 ELACYT 58 ADVEXIN therapy 58 SAR# [004] 58 JAK inhibitor 58 vidofludimus 58 HuMax CD# 58 MNTX 58 NovoTTF #A 58 Vidofludimus 58 Diamyd r 58 Plicera 58 oncolytic virus 58 SNT-MC#/idebenone 58 cetuximab Erbitux 58 TLR9 agonist 58 BNC# 58 zalutumumab 58 TH# [003] 58 ara C 58 TheraSphere ® 58 Annamycin 58 CIMZIA ™ 58 subcutaneous SC 58 invasive candidiasis 58 Cotara 58 ER CHOP 58 noninfectious uveitis 58 Pentacel vaccine 58 BRAF V# mutation 58 Aethlon Hemopurifier 58 ALA PDT 58 neoadjuvant therapy 58 riociguat 58 basal bolus regimen 58 ROTARIX 58 delipidation 58 Phase Ib clinical 58 VIDAZA 58 PGL# 58 hA# 58 Pentacel 58 nucleoside analogs 58 Myocet 58 subcutaneous immunoglobulin 58 Sanvar R 58 Halaven 58 tesmilifene 58 Monoclonal antibody 58 inactivated vaccine 58 OPAXIO 58 tremelimumab 58 GV# [001] 58 huC# DM4 58 dacarbazine chemotherapy 58 Deferiprone 58 autologous SCT 58 NXL# 58 immune modulatory 58 Aflibercept 58 taxotere 58 Stage IIIb 58 Doxil ® 58 OncoVAX 58 resected pancreatic cancer 58 Belerofon 58 Imvamune R 58 Photodynamic therapy 58 ranibizumab Lucentis 58 nanopharmaceutical 58 ImClone Erbitux 58 L asparaginase 58 AZILECT ® 58 immunomodulatory therapy 58 Tocilizumab 58 OnDose 58 Isolagen Process 58 KRAS status 58 hepatocellular cancer 58 Mepact 58 Ceplene/IL-2 58 Trabectedin 58 fluvastatin 58 metastatic malignant 58 Orencia abatacept 58 targeted radiotherapeutic 58 DiabeCell R 58 Mitoxantrone 58 Arcalyst 58 Diamyd R 58 Advagraf 58 DEFLUX 58 Gemzar gemcitabine 58 alkylating agent 58 randomized controlled Phase 58 BREVAGen ™ 58 metastatic CRC 58 Adult Stem Cell Therapy 58 cilengitide 58 randomized Phase IIb 58 Pralatrexate 58 LHRH receptor positive 58 chemotherapy docetaxel 58 stereotactic radiotherapy 58 PEGylated 58 Factor VIIa 58 LHRH agonists 58 chemotherapeutic regimens 58 imatinib Gleevec 58 metastatic renal cell carcinoma 58 immunotherapeutic 58 Ceftobiprole 58 Cx# [002] 58 IV Busulfex 58 histamine dihydrochloride 58 vincristine doxorubicin 58 TAXOTERE R 58 bendamustine 58 anticancer therapeutics 58 antibiotic regimens 58 adjuvant trastuzumab 58 Sutent sunitinib malate 58 Tasigna nilotinib 58 chemotherapeutic drug 58 Abacavir 58 Celution System 58 Hizentra 58 TPI ASM8 58 Valopicitabine 58 dirucotide MBP# 58 GeoVax vaccine 58 aerosolized KL4 surfactant 58 Tygacil 58 Fibrin Pad 58 Vion Pharmaceuticals 58 Humira adalimumab 57 Docetaxel 57 noscapine 57 BioNumerik 57 StrataGraft 57 NOD SCID mice 57 Jevtana 57 TransVax 57 dimeglumine 57 Seliciclib 57 Dapagliflozin 57 AMEVIVE 57 CyPath ® 57 Merck KGaA Erbitux 57 Anticalins ® 57 mTOR inhibitor 57 antitumor effect 57 Anavex #-# 57 complete cytogenetic response 57 Orazol 57 Nilotinib 57 Vandetanib 57 CERVARIX 57 Imatinib Mesylate 57 talabostat 57 Mabthera 57 Kombiglyze XR 57 AA amyloidosis 57 #mg ATC 57 XYOTAX TM 57 Dynavax HBV vaccine 57 HepaGam B TM 57 tramiprosate Alzhemed TM 57 Mirasol PRT system 57 resminostat 57 Amorcyte 57 Eculizumab 57 Peginterferon alfa 2b 57 Daclizumab 57 Copegus ribavirin 57 Islet transplantation 57 Endoscopic Ablation System 57 anti CD# antibodies 57 imatinib mesylate Gleevec 57 Deforolimus 57 MIBG 57 Panzem 57 phase IIb study 57 Bronchial Thermoplasty 57 biologic therapy 57 intravenous IV infusion 57 Hemopurifier TM 57 CellCept mycophenolate mofetil 57 Tracleer R 57 Ilaris 57 quinolone antibiotic 57 SPRIX ® 57 edifoligide 57 Bacillus Calmette Guerin BCG 57 Curaxin CBLC# 57 IVIG therapy 57 PLX cells 57 Trobalt 57 therapeutic monoclonal antibody 57 HCD# [002] 57 Firazyr 57 Roche Herceptin 57 bolus dose 57 diagnosed glioblastoma 57 intravesical instillation 57 gemcitabine Gemzar ® 57 Cogane 57 AA Amyloidosis 57 APTIVUS 57 OvPlex 57 Etoposide 57 interferon lozenges 57 Tovaxin TM 57 REMUNE R 57 ASSERT trial 57 Carboplatin 57 Sapacitabine 57 bevacizumab Avastin Genentech 57 EndoTAG TM 57 SUTENT ® 57 CDP# 57 Vascugel ® 57 TRISENOX 57 cisplatin chemotherapy 57 Taxol paclitaxel 57 chronic granulomatous disease 57 Junovan 57 hepatorenal syndrome 57 Nanobodies ® 57 follicular Non Hodgkin 57 Electronic Brachytherapy 57 regorafenib 57 Golimumab 57 cytotoxic therapy 57 gemcitabine chemotherapy 57 JVRS 57 TroVax 57 HDL Selective Delipidation 57 Ethyol 57 pain palliation 57 Cytolin ® 57 drug GAP #B# 57 Pirfenidone 57 Telcyta 57 EDEMA3 57 IMVAMUNE ® 57 evaluating tivozanib 57 renoprotective 57 Guanilib 57 ticagrelor Brilinta 57 eniluracil 57 Transcranial Magnetic Stimulation TMS 57 Cloretazine VNP#M 57 Mycamine 57 including eniluracil ADH 57 RoActemra 57 therapeutic monoclonal antibodies 57 CBLC# 57 HBV vaccine 57 recurrent metastatic ovarian cancer 57 Traficet EN 57 Neupro R 57 MenACWY 57 porcine derived 57 Pyridorin 57 WILEX 57 antibiotic azithromycin 57 Glioblastoma multiforme 57 Axiogenesis 57 molecularly targeted therapy 57 Omacetaxine 57 Provecta TM 57 transcutaneous immunization TCI 57 ganaxolone 57 Phase III VISTA 57 MVA BN ® 57 huN# DM1 57 immunotoxin 57 Blinatumomab 57 Multiferon R 57 Gemzar ® 57 metastatic colorectal 57 PDE4 inhibitor 57 recurrent glioblastoma 57 Glybera 57 omacetaxine mepesuccinate 57 refractory ovarian cancer 57 pancreatic enzyme replacement 57 luteinizing hormone releasing 57 LHRH antagonist 57 MYCAMINE 57 Raltegravir 57 STELARA ™ 57 differentiated thyroid 57 Caelyx 57 TriGrid 57 adecatumumab 57 VerifyNow 57 eligen 57 Corus CAD 57 prospective randomized multicenter 57 phase IIb III 57 laninamivir 57 Onbrez Breezhaler 57 tigecycline 57 gemtuzumab ozogamicin 57 DIABECELL 57 Neoadjuvant 57 BeneFIX 57 EchoCRT 57 debulking surgery 57 Zebinix 57 androgen receptor antagonist 57 #I TM# 57 Neovasc Reducer 57 Vaxfectin 57 Chronic myeloid leukemia 57 TLR agonists 57 CCR5 inhibitor 57 Lodamin 57 LODOTRA 57 Zometa zoledronic acid 57 Tacrolimus 57 dasatinib Sprycel 57 Romiplostim 57 recombinant erythropoietin 57 Treanda